High Prevalence of Diabetes Increases Uptake of Obesity-Fighting Drugs, Observes Report: MarketResearchReports.biz
MarketResearchReports.biz has announced the addition of a new research report to its vast repository. The research report, titled "Global Diabetes And Obesity Drugs Market To 2022 - Insulins And GPCRs Retain Commercial Prominence, While High Unmet Need Remains In Weight Loss Treatment," offers a comprehensive overview of the global diabetes and obesity drugs market. Diabetes, categorized as type 1, type 2, and juvenile diabetes, is a result of dysfunctional insulin secretion or absorption. In the long term, this non-communicable condition...
View full press release